endometrial carcinomas - Globe Thesis

Keyword [endometrial carcinomas] Result: 1 - 20 \| Page: 1 of 1
1.	Angiogenesis Of Endometrial Carcinomas Assessed By Measurment Of Intratumoral Blood Flow, Microvessel Density And Vascular Endothelial Growth Factor
2.	PTEN Mutations And Protein Expression In Endometrial Carcinomas
3.	Study On The Clinico-Biological Characteristics Of The Isoforms Of Progestrone Receptors In Endometrial Carcinomas
4.	Homozygous Deletions Of Exon5, 8 And Protein Expression Of The Tumor-suppressor Gene FHIT In Endometrial Carcinomas
5.	Expression Of Tumor Suppreor Gene PTEN And Cell Cycle Regulator P27 In Endometrial Adnocarcinoma
6.	Expression And Correlation Of Urokinasetype Plasminogen Activator, UPA And Urokinasetype Plasminogen Activator Inhibitor, PAI-1 And Receptors For Estrogen And Progestogen In Endometrial Carcinomas
7.	Expression And Clinical Significance Of ER, PR, P53, Ki-67 And Survivin In Endometrial Carcinomas: A Clinical Analysis Of 124 Cases With Endometrial Carcinoma
8.	Study Of Expression Of Telomerase Htert And Cell Cycle Regulaor P27 And The Association Between Them In Endometrial Adenocarcinoma
9.	Expression And Correlation Of Urokinase-type Plasminogen Activator (uPA) And Its Receptor (uPAR) And Mitogen Activated Protein Kinase (MAPK) P38 In Endometrial Carcinomas
10.	Urine Human Epididymis Protein4(HE4) As A Biomarker For The Diagnosis And The Differential Diagnosis Of Ovarian And Endometrial Carcinomas
11.	Parts Of Endometrial And Ovarian Cancer Primary Expression Of C-myc Double K-ras Protein Is
12.	Study On Biomarkers For Low-and High-grade Serous Ovarian Carcinomas Clinical Analysis Of Ovarian Preservation For Endometrial Carcinomas In Women Aged40Years And Younger
13.	Metabolomics Study Of Type Ⅰ Endometrial Carcinomas Using A Combined Approach Of GC-TOF-MS And UHPLC-MS/MS
14.	The Expression Of Tumor Suppressor PDCD4 In Endometrioid Endometrial Carcinomas And Clinico-pathological Significance
15.	Expression And Significance Of E-cadherin And Fascin In Dedifferentiated/Undifferentiated Endometrial Carcinomas
16.	The Expression Of MTA2 In Endometrial Carcinomas And The Correlation With Clinicopathological Features
17.	The Expression And Clinicopathological Significance Of Mismatch Repair Proteins (MLH1,MSH2,MSH6 And PMS2) In Endometrial Carcinomas
18.	Expression And Significance Of SOX2 And ER In The Endometrial Carcinomas
19.	Clinicopathological Features And Prognosis Of POLE-mutated Patients In High-grade Endometrial Carcinomas
20.	The Clinicopathologic Features,CD8~+T Lymphocyte Infiltration And Prognosis Of Endometrial Carcinomas With Mismatch Repair Deficiency
<<First <Prev Next> Last>> Jump to